ICML 2017 | The use of immuno-oncology in lymphoma
Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil from Oxford University Hospital, Oxford, UK, provides an overview of his session on the use of immuno-oncology in lymphoma at the International Conference on Malignant Lymphoma (ICML) 2017 in Lugano, Switzerland. The session was largely speculative on the role that immuno-oncology drugs can play in treating lymphoma. Immuno-oncology has been shown to be effective in Hodgkin lymphoma, however, this hasn’t been replicated in non-Hodgkin lymphoma. There is the potential for biomarkers to identify which patients may benefit from these drugs, however, more research needs to be completed in this area. This video has been supported by Napp Pharmaceuticals Ltd through an unrestricted educational grant to Magdalen Medical Publishing.
